Who are Endometrin's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Progesteron, Progesterone, PROGESTERONE, Progesterone Vaginal Gel [Crinone], Mifepristone tablets, Mifepristone + Misoprostol.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/endometrin.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-14 · How we verify

Endometrin — Competitive Intelligence Brief

Endometrin (progesterone) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Progesterone [EPC]. Area: Women's Health.

marketed Progesterone [EPC] Corticosteroid-binding globulin, Sodium/nucleoside cotransporter 1, Cation channel sperm-associated protein 1 Women's Health Live · refreshed every 30 min

Target snapshot

Endometrin (progesterone) — Ferring.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Endometrin TARGET	progesterone	Ferring	marketed	Progesterone [EPC]	Corticosteroid-binding globulin, Sodium/nucleoside cotransporter 1, Cation channel sperm-associated protein 1
Progesteron	Progesteron	Minia University	marketed		Corticosteroid-binding globulin, Sodium/nucleoside cotransporter 1, Cation channel sperm-associated protein 1
Progesterone	Progesterone plus HCG	Dunamenti REK Istenhegyi IVF Center	marketed	Progesterone [EPC]	progesterone receptor, luteinizing hormone/choriogonadotropin receptor	1978-01-01
PROGESTERONE	PROGESTERONE		marketed	Progesterone [EPC]		1976-01-01
Progesterone Vaginal Gel [Crinone]	Progesterone Vaginal Gel [Crinone]	Memorial Sisli Hospital, Istanbul	marketed	Progestin; Progesterone receptor agonist	Progesterone receptor (PR)
Mifepristone tablets	Mifepristone tablets	China Resources Zizhu Pharmaceutical Co., Ltd.	marketed	Progesterone receptor antagonist	Progesterone receptor (PR)
Mifepristone + Misoprostol	Mifepristone + Misoprostol	Gynuity Health Projects	marketed	Progesterone receptor antagonist + prostaglandin analog combination	Progesterone receptor (PR); prostaglandin E1 receptor (EP receptor)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

2029-02-03 — Endometrin · 10548904 · Method of Use · US
2029-02-03 — Endometrin · 10537584 · Formulation · US
2030-01-21 — Endometrin · 8580293 · Method of Use · US

Sponsor landscape (Progesterone [EPC] class)

· 1 drug in this class
Dunamenti REK Istenhegyi IVF Center · 1 drug in this class
Ferring · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Endometrin — Competitive Intelligence Brief. https://druglandscape.com/ci/endometrin. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab